# Antenatal Chlamydia Trachomatis and Neisseria Gonorrhoeae Testing to Prevent Adverse Neonatal Consequences

> **NCT04955717** · NA · COMPLETED · sponsor: **University of Southern California** · enrollment: 500 (actual)

## Conditions studied

- Chlamydia Trachomatis Infection
- Neonatal Infection
- Preterm Birth
- Gonorrhea

## Interventions

- **OTHER:** Chlamydia trachomatis and Neisseria gonorrhoeae screening using the GeneXpert

## Key facts

- **NCT ID:** NCT04955717
- **Lead sponsor:** University of Southern California
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-24
- **Primary completion:** 2023-01-31
- **Final completion:** 2023-01-31
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2025-02-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04955717

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04955717, "Antenatal Chlamydia Trachomatis and Neisseria Gonorrhoeae Testing to Prevent Adverse Neonatal Consequences". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT04955717. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*